Pharma Industry Regulation
12.3K views | +17 today
Scooped by Pharma Guy
onto Pharma Industry Regulation!

Trump Names Lawyer Lobbyist Without Any Medical/Science Background At All to Head FDA During Transition

Trump Names Lawyer Lobbyist Without Any Medical/Science Background At All to Head FDA During Transition | Pharma Industry Regulation |

Longtime pharmaceutical lobbyist Jack Kalavritinos, who also worked in various capacities for the George W. Bush administration, will take a major role on the “beachhead” team that the incoming Trump administration is sending to run the Food and Drug Administration following Friday’s inauguration, transition team sources say.


Kalavritinos spent seven years as director of global lobbying for the Irish pharmaceutical and medical device company Covidien, which sells a wide array of hospital supplies around the world. The US company Medtronic bought Covidien in 2014 and promptly moved its headquarters to Ireland, which has a lower corporate tax rate.


Such “inversions” — deals structured to let American companies take advantage of lower tax rates overseas — began to draw heavy public ire around the time of the Medtronic-Covidien deal. The Obama administration has sought to crack down on such transactions with new rules from the Treasury Department.


President-elect Donald Trump seemed to be referring to such deals, as well as the outsourcing of manufacturing, when he recently accused the pharmaceutical industry of “getting away with murder.”


“Our drug industry has been disastrous,” Trump said at his first post-election news conference. “They’re leaving left and right.”


Further Reading:

Pharma Guy's insight:

Jack Kalavritinos has a law degree from The Catholic University of America, Columbus School of Law. So he’s a religious Catholic and probably opposed to contraception and women’s rights. As far as his pharma experience, he worked for Covidien as a lobbyist (“government affairs advisor”) after various stints in the Washington bureaucratic “swamp.”


We all know that "interim" FDA heads may hold that position for months!

No comment yet.
Pharma Industry Regulation
Stories & Insights Regarding Marketing Regulations & Guidelines
Curated by Pharma Guy